Hapten Sciences
Pre-clinicalHapten Sciences identifies and efficiently develops novel, early-stage products that will contribute to the well being of people around the world.
Founded
2012
Focus
Small Molecules
About
Hapten Sciences identifies and efficiently develops novel, early-stage products that will contribute to the well being of people around the world.
Funding History
2Total raised: $50M
Series B$35MUndisclosedSep 15, 2022
Series A$15MUndisclosedMay 15, 2020
Company Info
TypePrivate
Founded2012
LocationMemphis, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile